Overview
No overview information available.
Background
No background information available.
Indication
抗贫血药。用于预防和治疗各种原因引起的缺铁性贫血，包括儿童或婴儿期需铁量增加而食物中供应不足、铁吸收障碍、妊娠中后期以及慢性失血等。
Associated Conditions
No associated conditions information available.
Clinical Trials
Title | Posted | Study ID | Phase | Status | Sponsor |
|---|---|---|---|---|---|
2024/07/05 | Phase 2 | Not yet recruiting | The Second Hospital of Nanjing Medical University |
FDA Drug Approvals
Approved Product | Manufacturer | NDC Code | Route | Strength | Effective Date |
|---|---|---|---|---|---|
| No FDA approvals found for this drug. | |||||
EMA Drug Approvals
Approved Product | Authorization Holder | Status | Issued Date |
|---|---|---|---|
| No EMA approvals found for this drug. | |||
HSA Drug Approvals
Approved Product | Manufacturer | Approval Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No HSA approvals found for this drug. | |||||
NMPA Drug Approvals
Approved Product | Company | Approval Number | Drug Type | Dosage Form | Approval Date |
|---|---|---|---|---|---|
| Ferrous Lactate Syrup | 国药准字H20061274 | 化学药品 | 糖浆剂 | 8/6/2021 | |
| Ferrous Lactate Tablets | 国药准字H20020740 | 化学药品 | 片剂 | 7/11/2020 | |
| Ferrous Lactate Tablets | 国药准字H20020074 | 化学药品 | 片剂 | 6/28/2020 | |
| Ferrous Lactate Oral Solution | 国药准字H20044874 | 化学药品 | 口服溶液剂 | 3/23/2020 | |
| Ferrous Lactate Capsules | 国药准字H20193145 | 化学药品 | 胶囊剂 | 3/21/2024 | |
| Ferrous Lactate Capsules | 国药准字H20000448 | 化学药品 | 胶囊剂 | 7/23/2020 |
PPB Drug Approvals
Approved Product | Registration No. | Company | Licence No. | Strength | Registration Date |
|---|---|---|---|---|---|
| No PPB approvals found for this drug. | |||||
TGA Drug Approvals
Approved Product | ARTG ID | Sponsor | Registration Type | Status | Registration Date |
|---|---|---|---|---|---|
| No TGA approvals found for this drug. | |||||